| Project Detail |
This project supports the construction, furnishing and validation of a multi-vaccine manufacturing facility by an established Promoter that is a national supplier of vaccines. Objectives The project supports the Promoter to scale up their current fill and finish vaccine manufacturing facility and expand into an end-to-end multi-vaccine manufacturing facility. At completion the facility will include a drug substance suite as well as formulation, fill, finish, quality control and release capabilities for commercial scale vaccine production. Additionally, the project is expected to facilitate technology transfer of vaccines for infectious diseases included in routine immunisation schedules. Sector(s) Industry - Manufacturing Under Global Europe NDICI guarantee Under EFSD+ Guarantee Proposed EIB finance (Approximate amount) EUR 75 million Total cost (Approximate amount) EUR 177 million |
